NCT00126386View on ClinicalTrials.gov

Zometa for the Management of Tumor-induced Hypercalcemia and Malignant Bone Pain in the Community

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

September 30, 2006

Conditions
CancerHypercalcemiaPain
Interventions
DRUG

Zoledronic acid (Zometa)

Trial Locations (1)

T2N 4N2

Tom Baker Cancer Centre, Calgary

All Listed Sponsors
lead

Alberta Health services

OTHER

NCT00126386 - Zometa for the Management of Tumor-induced Hypercalcemia and Malignant Bone Pain in the Community | Biotech Hunter | Biotech Hunter